SCHEMBL31229776

SCHEMBL31229776

O=C(O)c1cc2sc(-c3ccccc3)cc2[nH]c1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
GAA P10253 3/20 0.49
HPGD P15428 2/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
KDM4E B2RXH2 5/20 0.46
ERCC5 P28715 1/20 0.45
FEN1 P39748 1/20 0.45
RAB9A P51151 5/20 0.43
NPC1 O15118 3/20 0.43
NPSR1 Q6W5P4 2/20 0.43
MAPT P10636 2/20 0.43
PTPN5 P54829 1/20 0.43
PARP1 P09874 1/20 0.42
IKBKB O14920 1/20 0.41
UCHL1 P09936 2/20 0.40
LMNA P02545 1/20 0.40
UCHL3 P15374 1/20 0.40
TGM2 P21980 1/20 0.40
CASP3 P42574 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31229592 0.83 ALDH1A1 (0.58) ALDH1A1GAAHPGDMEN1KMT2A
SCHEMBL31229697 0.82 MCL1 (0.43) ALDH1A1GAAHPGDKDM4EMAPT
SCHEMBL69502 0.80 DAO (0.51) ALDH1A1GAAHPGDMEN1KMT2A
SCHEMBL31229651 0.75 KDM4E (0.42) ALDH1A1GAAHPGDKDM4EPARP1
SCHEMBL31229812 0.73 KDM4E (0.43) ALDH1A1GAAHPGDKDM4EUCHL1
SCHEMBL31229599 0.72 KDM4E (0.42) ALDH1A1GAAHPGDKDM4EUCHL1
SCHEMBL31229802 0.72 HSD17B10 (0.46) ALDH1A1GAAHPGDKDM4EUCHL1
SCHEMBL31229807 0.72 KDM4E (0.39) ALDH1A1GAAHPGDKDM4EPARP1
SCHEMBL9098195 0.71 ERCC5 (0.48) ALDH1A1GAAHPGDKDM4EERCC5
SCHEMBL4146436 0.71 DAO (0.61) ALDH1A1GAAHPGDKDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024222866-A1 CYCLIC DERIVATIVES, COMPOSITIONS AND USES THEREOF DANATLAS PHARMACEUTICALS CO., LTD. (CN) 2024-10-31 WO disclosed